Please assess the completion status of the following clinical trial:

Trial Title: Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria :~* Major patient;~* Having an indication for placement of PRG (percutaneous radiological gastrostomy);~* Patient hospitalized for a minimum of 24 hours post gastrostomy;~Non-inclusion criteria :~* Pregnant or lactating woman;~* Legal incapacity or limited legal capacity. Medical or psychological conditions which do not allow the subject to understand the study and sign the consent (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9);~* Not knowing how to read and / or write French;~* Allergy and / or known hypersensitivity to lidocaine and / or ropivacaine or to other local anesthetics with amide bond or to one of the excipients;~* Recurrent porphyrias (genetic, hereditary diseases affecting the production of hemoglobin);~* Patient on beta blockers during the installation of PRG (Percutaneous Radiological Gastrostomy);~* Indication of gastrostomy button placement.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Patients will receive Lidocaine alone during percutaneous gastrostomy under radiological guidance
- Lidocaine and Ropivacaine (Type: EXPERIMENTAL): Patients will receive Lidocaine and Ropivacaine during percutaneous gastrostomy under radiological guidance

Based on this trial design, predict the completion outcome and termination type (if applicable).